PILL241115C9000
- 0.00
- 0.000.00%
Direxion Daily Pharmaceutical & Medical Bull 3X Shares Newsroom
Baupost's Top Q3 Trades Include Jazz Exit, New Dollar General Stake
10 Health Care Stocks With Whale Alerts In Today's Session
This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock
US Stock Ranking: Bristol-Myers Squibb surges more than 10%.
■ Top Volume Stocks Closing Price Change from Previous Day %Tesla 350.00 +28.78 +8.96% Nvidia 145.26 -2.37 -1.61% Intel 25.05 -1.15 -4.39% Palantir Technologies Inc 60.24 +1.85 +3.17% Super Micro Computer 23.23 -1.29 -5.26% Apple 224.23 -2.73 -1.20% Bank of America Corp 46.08
What's Going On With Bristol-Myers Squibb Shares Monday?
How AbbVie Can Still Benefit From Cerevel Acquisition Despite Emraclidine Setback
Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal
AbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges
MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday
AbbVie Declines After Missing Main Goal in Schizophrenia Treatment Trials
14 Out of 18 Healthcare Companies Beat Profit Estimates This Week- Earnings Scorecard
Insider Trades: Notable Buys and Sells by Significant Shareholders, Executives and Directors
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
Viatris Analyst Ratings
Edgewise Therapeutics Analyst Ratings
UK Parents Want National Health Service To Allow Cannabis For Children With Epilepsy
Wall Street Closes At Record Highs After Reassurance From Powell: Magnificent 7 Hit $17 Trillion, Treasury Yields Erase Post-Election Spike
Edgewise Therapeutics Shares Are Trading Lower. The Company Reported Q3 Financial Results.
Generic Drugmaker Viatris Beats Expectations In Q3, CEO Praises $2 Billion Debt Paydown